EcoDrugPlus

Aph-1 Homolog A, Gamma-Secretase Subunit

Ensembl ID : ENSCSEG00000010946
Gene Symbol: APH1A
3 Cross references
193 Possible Orthologues:

Apurinic/apyrimidinic Endodeoxyribonuclease 1

Ensembl ID : ENSCSEG00000017499
Gene Symbol: APEX1
3 Cross references
214 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSCSEG00000006607
Gene Symbol: ALOX5
3 Cross references
212 Possible Orthologues:

Arg8-Vasotocin Receptor-Like

Ensembl ID : ENSCSEG00000008267
Gene Symbol: LOC103380287
3 Cross references
203 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSCSEG00000004367
Gene Symbol: AVPR1A
3 Cross references
186 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSCSEG00000009165
Gene Symbol: AVPR2
2 Cross references
166 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSCSEG00000001404
Gene Symbol: AVPR2
3 Cross references
210 Possible Orthologues:

Aromatase-Like

Ensembl ID : ENSCSEG00000006295
Gene Symbol: LOC103378914
3 Cross references
255 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 3-Like

Ensembl ID : ENSCSEG00000011131
Gene Symbol: LOC103397062
3 Cross references
209 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 3-Like

Ensembl ID : ENSCSEG00000009193
Gene Symbol: LOC103397486
3 Cross references
209 Possible Orthologues:

Aurora Kinase B-Like

Ensembl ID : ENSCSEG00000003195
Gene Symbol: LOC103390609
3 Cross references
205 Possible Orthologues:

Aurora Kinase C

Ensembl ID : ENSCSEG00000018676
Gene Symbol: LOC103386685
3 Cross references
233 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).